A detailed history of Adar1 Capital Management, LLC transactions in Liquidia Corp stock. As of the latest transaction made, Adar1 Capital Management, LLC holds 9,285 shares of LQDA stock, worth $109,563. This represents 0.02% of its overall portfolio holdings.

Number of Shares
9,285
Holding current value
$109,563
% of portfolio
0.02%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$8.9 - $14.11 $82,636 - $131,011
9,285 New
9,285 $92.9 Million
Q1 2024

May 15, 2024

BUY
$11.35 - $16.73 $22,700 - $33,460
2,000 New
2,000 $29.5 Million

Others Institutions Holding LQDA

About Liquidia Corp


  • Ticker LQDA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 64,362,300
  • Market Cap $759M
  • Description
  • Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension. It also distributes generic treprostinil inje...
More about LQDA
Track This Portfolio

Track Adar1 Capital Management, LLC Portfolio

Follow Adar1 Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Adar1 Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Adar1 Capital Management, LLC with notifications on news.